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Background: Over the last 50 years, mortality and morbidity from liver disease has 
increased and is a global health concern (Global Burden of Disease, 2020). In the 
United Kingdom, within this time frame, liver mortality has risen by 500% in the under 
65-year age group (British Liver Trust, 2019). Treating and caring for patients with liver 
disease is complex, therefore it is imperative to educate health care professionals 
regarding the different types of liver conditions, the treatments and care required to 
support patients.  
Aims: The critical appraisal spans over 14 years of research and will examine 19 
publications which details the impact of the author’s research on their academic 
journey, from a student nurse to the present day; underpinned by Benner’s (1984) five 
stage theoretical framework. This appraisal demonstrates how the impact of the 
author’s research, nursing practice and published papers is advancing health 
professionals’ knowledge of liver disease within national and international arenas. It 
additionally evidences how the research has improved standards of medical and 
nursing care for patients receiving treatment for liver disease and establish how, by 
listening and responding to patient experiences, guided the research and assisted in 
the development of educational resources. 
Methodology: The research chronologically encompassed positivist, interpretivist, 
and latterly pragmatic paradigms and utilised both quantitative and qualitative 
research methodologies. The research generated new knowledge regarding patients’ 
lived experiences of haemochromatosis, generated data submitted to Parliament and 





Findings: The principal findings of the research demonstrated that there was a 
disparity of care across the British Isles, for people undergoing therapeutic 
venesection for haemochromatosis. This prompted the development of the 
venesection guidelines to standardise practice. A further finding demonstrated that 
less than 27,000 people were being treated for genetic haemochromatosis when the 
numbers should be nearer to 400,000 indicating that the condition is underdiagnosed.  
A further qualitative study highlighted that many General Practitioners take years to 
diagnose the condition, and some were unaware of its existence.  
Impact: The author’s expertise and research reputation, as evidenced by the 
collection of published research, has been sought by the National Institute of Health 
and Care Excellence (NICE) for the development of national guidelines and quality 
standards. The contribution from the author was recognised by NICE by the 
conferment of the title, NICE Expert. Research findings were presented to Parliament 
via an All-Party Parliamentary Group in 2020, to highlight the condition, genetic 
haemochromatosis and to lobby for increased awareness. The Venesection Best 
Practice Guide received Royal College of Nursing endorsement and was published as 
and eBook which has been downloaded by many countries, evidencing worldwide 
dissemination. This project won the National Patient Safety Learning Award in 2018 
and in addition, the co-authors have been awarded winners of Nurse of the Year, 2021 
by the British Journal of Nursing. This clearly demonstrates how the author has 
advanced health professionals’ knowledge of liver disease by informing and 
influencing local, national, and international policy to improve or even transform lives 






1.1 Liver Disease 
Liver disease is a worldwide issue (Global Burden of Disease [GBD], 2020) and 
recognised as a silent killer. Over the last 40 years, the United Kingdom (UK) has 
witnessed an exponential increase in liver disease mortality whereas death rates from 
other medical conditions such as: heart, respiratory disease and cancer have fallen, 
(Public Health England [PHE], 2020; British Liver Trust [BLT], 2019; Williams et al., 
2018; Williams, 2015; British Society of Gastroenterology [BSG], 2009). 
Liver disease is recognised as the fifth leading cause of death worldwide and within 
the UK, is the third most common cause of premature death in the under 65-year age 
group (Public Health England [PHE], 2020; BLT, 2019; PHE, 2017; British Society of 
Gastroenterology [BSG], 2009) with death rates within this cohort group increasing by 
over 500% since the 1970’s (BLT, 2019). These findings are supported by data 
published in 2015 by PHE and additionally state that over 600,000 people in the UK 
have some form of serious liver disease with over 60,000 diagnosed with liver 
cirrhosis. Further statistics published in the Lancet Standing Commission on Liver 
Disease in the UK report, emphasised this stark reality and added that liver disease 
will shortly overtake ischaemic heart disease regarding years of working life lost 
(Williams et al., 2017). 
Unfortunately, signs of liver disease are generally not apparent unless it has reached 
an advanced stage, evidenced by jaundice, ascites, oesophageal and gastric varices, 
all late signs of portal hypertension (Bacon, O'Grady, DiBisceglie, Lake, 2005. This is 
supported by research from the NIHR Southampton Biomedical Research Centre 
(2020) who established that 75% of people with liver cirrhosis were not diagnosed in 





treatment options were limited. Therefore, liver disease is acknowledged as the silent 
killer (BLT, 2021). 
The main causes of liver disease are modifiable such as: alcohol related liver disease, 
fatty liver secondary to obesity, and viral hepatitis (PHE, 2020). However, there are 
other causes, such genetic haemochromatosis that tend to be overlooked.  
1.2 Genetic Haemochromatosis 
Over the last 20 years my research interest into liver disease has grown and developed 
with a specific focus upon genetic haemochromatosis. Genetic haemochromatosis is 
the most common genetic disorder affecting Caucasians in the UK, but people are 
not aware it exists (Haemochromatosis UK [HUK], 2020). It is an autosomal recessive 
disorder which requires a person to inherit one copy of a variant (mutated) gene from 
each parent to develop the condition. Inheriting two copies is termed homozygous or 
homozygote (Fitzsimons et al., 2018; European Association of the Study of the Liver 
[EASL] 2010). If only one copy is inherited, then that person is termed heterozygous, 
otherwise known as a “carrier” of the condition. 
Haemochromatosis causes the body to absorb too much iron from the diet. Over time, 
the iron accumulates and is deposited throughout the organs of the body, including 
the skin, and joints. However, because the liver is the body’s main storage place for 
iron, any excess is deposited there, and liver disease usually precedes significant 
disease in other organs (Mortimore, 2017b; Bacon et al., 2005). Due to the non-
specific nature of early symptoms of haemochromatosis, diagnosis can be incorrectly 
diagnosed, missed, or delayed until more serious signs and symptoms have appeared, 





Once diagnosed the mainstay of treatment is the therapeutic removal of blood, 
approximately 450mls, known as venesection (Francis, Mortimore and HUK, 2020; 
Fitzsimons et al., 2018; EASL, 2010). In the de-ironing phase, as iron levels are 
brought down to normal levels, venesection can occur weekly or fortnightly for many 
weeks, months or years depending on initial ferritin levels. Once the iron has been 
successfully removed and ferritin levels brought down to within normal levels then 
patients are in maintenance and venesections are then required approximately every 
two to four months for the rest of their lives (Fitzsimons et al., 2018; EASL, 2010). 
There are other rarer types of iron overload but Type 1 genetic haemochromatosis is 
the most common and has been passed down through the Northern European 
bloodline especially Celtic, Picts and Viking.  Research reveals that 1:113 people in 
Scotland and Ireland have the disease and 1:150 in England and Wales (HUK, 2020; 
Pilling et al., 2019). This is interesting to note, as in an article authored by Mortimore 
(2017b) only two years earlier, cited the American Association of the Study of Liver 
Disease guidelines on haemochromatosis which suggested that the numbers affected 
were less, at around 1:200 (Bacon et al., 2011). 
In 2019, research undertaken by the University of Exeter Biobank established that 
within the UK over 380,000 people have haemochromatosis. However, after obtaining 
information from NHS hospitals under the Freedom of Information (FOI) Act, (2000) it 
was apparent that only around 20,000 people were being treated within NHS Trusts 
(Mortimore and McClements, 2020). Even if this number was optimistically doubled 
to account for the NHS Trusts that did not respond to the FOI, this is a serious 
underestimate. This ultimately will have a profound long-term medical and financial 
consequences to the NHS, as undiagnosed patients may develop complications of 





presentation to an All-Party Parliamentary Group in Westminster to lobby Government 
for calls to action to tackle this issue (Mortimore and McClements, 2020a) (Chapter 
3). 
1.3 Responding to the educational needs of health care practitioners 
The complex nature of liver disease morbidity and mortality denote the requirement of 
educating health care professionals (HCPs) regarding liver disease; its causes, 
complications, and treatment, to help improve the quality of care provided to patients 
and carers. This was acknowledged in 2013, when the Department of Health (DOH) 
in conjunction with the Royal College of Nursing (RCN) developed a competence 
framework for nurses and allied health professionals dealing with adults and young 
people with liver disease (RCN, 2013). This framework made clear the expectation 
that all HCPs should remain up to date; to keep abreast of skills and knowledge in the 
ever-evolving field of healthcare and liver disease, thereby ensuring that information 
or advice given to patients and carers is evidence based (Nursing and Midwifery 
Council [NMC], 2018). Despite an expectation from national drivers regarding liver 
disease education (BLT, 2019; Williams et al., 2017; PHE, 2017) it is surprising to find 
that there is a paucity of liver educational courses being delivered nationally. This point 
was raised in my publication in the Gastrointestinal Nursing journal, titled, “Advanced 
liver training: where are the courses?” (Mortimore, 2016a), with an acknowledgement 
that reading relevant journals and attending conferences, is often the easiest, most 
convenient, and cost-effective way HCPs can keep up to date. This continuing 
professional development for HCPs is prerequisite for professional revalidation by the 
General Medical Council (GMC) and the NMC and helps to improve the safety and 





Since 2006, I have published numerous articles regarding liver disease with the aim 
to advance health professionals knowledge. My expertise within the field of liver 
disease has been recognised with requests to speak at national conferences, author 
further articles and become a peer reviewer for nursing journals. It has also led to 
invites form pharmaceutical companies to offer advice for potential research studies 
in patients with liver cancer and contribute to teaching modules for nurses (Chapter 
4).  
1.4 Research and audit 
Audit, research and clinical trials are an everyday part of the National Health Service 
(NHS) and any robust research project relies on the ability to collect high quality data 
and to analyse it correctly. High quality data, in terms of validity and reliability, can 
inform and enhance evidence-based decisions and aid learning. Moreover, the 
evidence-based medicine (EBM) that we practise today, is attributable to past 
research. EBM requires the assimilation of high-quality research evidence along with 
clinical experience, expertise and patients’ values and experiences (Strauss et al., 
2019). Thus, research assists the NHS in its future healthcare, although it is 
recognised that a large proportion of health research is not only clinical trials, but 
information based.  
In a systematic review of the literature in a publication titled, “Towards Noninvasive 
Detection of Oesophageal Varices” (Rye, et al., 2012) we compared the standard 
endoscopy for the diagnosis of oesophageal varices in cirrhotic patients with clinical, 
biochemical, and radiological investigations. We concluded that these investigations 
were currently not accurate enough and potentially could miss the diagnosis of large 





numerous times (appendix 1) thereby demonstrating that this article has been used as 
evidence in further research, thereby contributing to EBM.   
Within this appraisal I will evidence how collecting data in the form of homogenous 
purposeful sampling (Braun and Clarke, 2013; Palinkas, et al., 2013) significantly 
contributed to audit and research studies. The findings of these studies resulted in 
changes to medical and nursing practise which enhanced the hepatology service and 
directly improved patient care.   
1.5 Patient and public involvement in research  
Within research, it is expected that there will be patient and public involvement (PPI) 
to make the research process more effective and representative of the patients’ needs 
(BSG 2018). PPI is key to undertaking any research and applying for research funding 
and increasingly recognised that the patient voice drives policy areas (Clempson, 
2016).  
Over recent years, the NHS, BSG, National Institute for Health and Care Excellence 
(NICE), National Institute for Health Research (NIHR) and pharmaceutical companies 
have become increasingly patient focussed, as they recognise the benefits of patient 
engagement to improve the quality of the research evidence (Pharmerit, 2020; NIHR, 
2020; NHS, 2020; NICE, 2013). For example, all pharmaceutical company clinical 
trials have Patient Related Outcome Measures tools (Austin, et al., 2019; Kingsley and 
Patel, 2017) to assist in the understanding of the degree of disease severity (Mokkink, 
et al., 2010). NHS Ethics committees, where all pharmaceutical and local research 
studies must apply to, actively examine any research proposal that directly or indirectly 





NICE involve patients when devising national guidelines and acknowledges that 
including them, “adds value to the discussions of the independent committees and 
working groups that develop NICE guidance” (NICE, 2013, pg. 2). Thus, the patient 
voice is essential as it assists in shaping the research, the guidelines, and the policies 
of the future.   
On a personal level, over the decades I have witnessed a paradigm shift from doctors 
paternalistically dictating to patients, to the present day, where patients are becoming 
actively involved in their treatment. Nurses, on the other hand, have always been 
recognised as the patient advocate, and this advocacy, in the form of empathy, patient 
protection and being the patients’ voice, facilitates effective nursing care (Nsiah, 
Siakwa and Ninnoni, 2019; Davoodvand, Abbaszadeh and Ahmadi, 2016).  
This thesis will evidence how listening to patient experiences and needs guided 
research and audit studies and assisted in the development of educational 
publications, all of which have advanced HCPs and patient’s knowledge of liver 
disease.   
1.6 Aims and purpose of this thesis 
This PhD by publication encompasses many years of academic research into liver 
disease which has generated new knowledge and offered guidance to health 
professionals, patients, and their carers nationally and internationally.  
The aims of this critical appraisal are to demonstrate: 
• the impact of my research, nursing practice and published papers in advancing 






• that my research has improved standards of medical and nursing care in 
patients receiving treatment for liver disease 
• listening and responding to patient experiences guides research and assists in 
the development of educational resources 
• the impact of my research contribution and how this has influenced my 
professional standing 
The first three aims follow-on from each other in a continuing cycle and could be 
described as part of a feedback loop to advance health professionals’ knowledge 
(figure 1). 
Figure 1: Aims of thesis as a continuous cycle 
1.7 Three themes of the thesis: 
This thesis is categorised through three themes and underpinned by Benner’s Novice 
to Expert theoretical framework (1984), which was adapted from the Dreyfus Model of 





reflect on my levels of clinical and research expertise: novice, advanced beginner, 
competent, proficient, and expert (Benner, 1984).  
1.7.1 Underpinning theoretical framework and female icons: 
Benner’s 1984 framework has been applied by other health professions and has been 
extensively cited over the decades, the latest being Murphy and Mortimore, (2020); 
Hoover, et al., (2020); Thomas and Kellgren (2017); McHugh and Lake (2010); 
Lyneham, Parkinson and Denholm (2008); Evans and Donnelly (2006); Meretoja, 
Isoaho, and Leino-Kilpi (2004). When Benner’s theoretical framework was published 
in 1984, I was a student nurse and I distinctly remember the feeling of inadequacy as 
a novice nurse, working in my first ward, which was then called psychogeriatrics and 
my second ward in acute general medicine. However, this thesis will demonstrate that 
over time, as my knowledge and experience increased, I not only attained Benner’s 
(1984) five levels of competence but surpassed them, to become an advanced expert 
and an internationally recognised researcher and policy influencer (Mortimore, 
Reynolds, Forman, Brannigan and Mitchell, 2021), (figure 2). Hence, applying 
Benner’s (1984) framework aptly reflects my personal journey and is fully aligned to 
addressing the research journey explored in this thesis. 
My research chronologically encompassed positivist, interpretivist, and latterly 
pragmatic paradigms, although on reflection, I feel I align more closely with the 
Pragmatic theorists/philosophers and in particular to Jane Adams. Much of her work 
was overlooked and associated with her male contemporaries such John Dewey, 
William James and George Mead (Stanford Encyclopaedia of Philosophy, 2018). This 
resonates with my own experience as a novice researcher, which I will expand on in 





authored works has come to light, mainly thanks to feminist historians and 
philosophers, and these works clearly denote her intellect and progressive, pragmatic 
thinking (Stanford Encyclopaedia of Philosophy, 2018; Haight and Bidwell, 2016; 
Shields, 2006). 
Although I admire Jane Adams, there is another important female icon that I deeply 
respect and that is Florence Nightingale. Although Florence was recognised as a 
statistician, with this work falling under the positivist paradigm, I would argue that she 
was one of the greatest female pragmatists before her time. Although most people 
associate her with the Crimean war; where she worked tirelessly to care for wounded 
British soldiers and improve cleanliness, sanitation, little focus has been given to her 






Figure 2: Derby Model: 7 levels of practice advancement (Mortimore, Reynolds, Forman, 
Brannigan and Mitchell, 2021) 
Florence went against her wealthy family’s wishes to become a nurse and arguably 





as health missionaries (Middleton-Smith, 2020). Florence visited what she termed the 
“poorly poor”, gifting them food and ensuring that they were cared for. Moreover, she 
spoke with local and London doctors to discuss and diagnose patients under her care, 
paid to support several families for many years, bought a waterbed for one of her 
patients and sent another down to London to be treated, which again she financed. In 
addition, she ordered numerous public health interventions to prevent the spread of 
disease, writing letters chronicling the dangers of living next to, or above a cesspool, 
warning about the potential of the water being contaminated by sewage (Middleton-
Smith, 2020). This clearly demonstrates Florence’s pragmatic approach, akin to 
Addams, using her wealth, intellect and status to improve the health and care of 
marginalised people in Derbyshire.  
1.7.2 Theme 1: Nurse practitioner and researcher: from novice to expert  
In chapter two, I provide a chronological evidence base of how my nursing and 
research experience developed from a novice to an advanced beginner, progressing 
through to a competent nurse researcher; recognising and collecting data that could 
potentially be utilised for audit and research purposes, through to a proficient 
researcher and expert nurse, where I recognised which data could contribute to 
research that would make a difference to patient care.  It will evidence how I perceived 
gaps in health care knowledge, devised and led audit and research studies thereby 







1.7.3 Theme 2: An influencer of national policy  
In chapter 3, I evidence how my extensive knowledge of liver disease and the nursing 
care required to look after this cohort of patients was recognised by NICE and my 
expertise utilised to inform national clinical guidelines and Quality Standards. 
Additionally, this chapter demonstrates how my research into genetic 
haemochromatosis identified the lack of standardised venesection practice within the 
UK. Authoring of venesection guidelines, endorsed by the Royal College of Nursing 
(RCN), led to implementation of the guidelines as nursing guidance for the UK and 
has assisted in standardising nursing care nationally and internationally (Francis, 
Mortimore and HUK, 2020). This research played a significant role in demonstrating 
my transition into the expert level of competence (Benner, 1984). 
Further exploration using my qualitative research study (Mortimore and Woodward, 
2019) into genetic haemochromatosis, along with published articles regarding this 
subject and Venesection guideline (Francis, Mortimore and HUK, 2020) contributed 
towards an invitation to become a member of an All Party, Parliamentary Group in 
Genetic Haemochromatosis, thus, informing policy at a Government level. All these 
contributions evidence my expert status as a nurse, academic and researcher, and 
provided a platform to raise liver disease awareness to HCPs and increase the profile 
of the University of Derby. 
1.7.4 Theme 3: An academic nurse practitioner and expert researcher 
delivering best practice in the clinical setting. 
Chapter four demonstrates how, as an academic and nurse practitioner, my published 
articles have assisted in the advancement of HCPs’ knowledge of liver disease and 
influenced my career and academic decisions. Moreover, it demonstrates how my 
publications have successfully increased my research reputation, as evidenced by my 





This chapter explores how my wealth of publications has led to invitations to speak at 
national conferences and local and national BBC radio interviews, all of which 
contributed to successful applications for funding to continue with research projects. It 
will additionally evidence how my research reputation drew the attention of 
international pharmaceutical companies who requested my services to act as a 
consultant advisor on several research and teaching projects, and how I continue to 
receive requests by editors to publish in national journals thereby increasing 
knowledge dissemination. This knowledge and expertise are currently used to educate 
HCPs undertaking their MSc in Advanced Clinical Practice. 
My contribution to national and international policy and research supports the PhD by 
publication route. The aims will be achieved through the presentation of nineteen 
publications to create a coherent study that evidences the development, synthesis, 














Chapter 2: Theme 1 - Nurse practitioner and researcher: from novice to expert 
 
2.1: Nursing and research journey                                                       
This chapter will reflect on my nursing and research career, commencing as a novice 
nurse and researcher in the 1980’s and 1990’s respectively, where I did not fully 
appreciate that patients’ knowledge, concerns, needs or educational requirements 
could help shape research hypotheses, or that these early research experiences 
would form the basis of my research philosophy. Additionally, this chapter will explore 
my first publication, what this meant to me and how it ignited my interest in research.  
As my insight into research developed, I recognised the value of data which I utilised 
for audit purposes and the findings of which, changed practice at the local hospital 
Trust. As my expertise grew, I recognised gaps in health care knowledge which 
enabled me to devise and lead on my own audit and research projects to advance 
understanding but most importantly improve the care delivered to patients. 
On reflection of my nursing career commencing in 1982, as a novice student nurse, I 
realise how my career, research, personal life, and environmental experience 
augmented my own knowledge base. According to Knowles, et al., (2015), a learner 
requires to be motivated, the greater this determination, the greater the depth of 
learning.  
2.2 Novice researcher 
My desire and curiosity for knowledge and skills for use in clinical practice (Knowles, 
et al., 2015) paved the way to learn new skills and in the late 1990’s, I assisted in 
biological research undertaking: Enzyme Linked Immunosorbent Assay (ELISA) to 
measure levels of cytokines and preparing human liver for slide fixation and staining 





the freshly removed liver, to weigh and then prepare for staining. This was unusual 
work for nurses to undertake and although I considered myself a “proficient nurse”, 
according to Benner’s Novice to Expert (1984) concept, I was a “novice” in terms of 
my research experience (figure 2). This was evidenced by the fact that although the 
laboratory work was pivotal to the research projects, and as there were only three 
people undertaking the laboratory work; the first and second author and myself, I was 
not included as an author on the final published research articles. At that time this did 
not cause me concern. I was happy to undertake the tasks I had been given as the 
doctor’s nurse assistant and as a nurse, I did not expect my name to be placed on 
published medical research. Only now, on reflection, I appreciate that this oversight 
should not have occurred. From an epistemological perspective, “I didn’t know what I 
didn’t know.” Philosophers such as Rorty (1979), consider that epistemology is pivotal 
to science as it offers a vantage point from which we can evaluate our claims to 
knowledge. My acceptance of the then “status quo” of nurse handmaiden to the 
medics (Summers, 2010), identified my lack of critical thinking and from an 
epistemological perspective, I could not be expected to develop or produce change as 
evidenced by the Dreyfus and Dreyfus (1980) and the works of Benner (1984).  
2.3 Reflection 
Reflecting on my novice approach to research, Korthagen (2004) states that reflection 
is vital for personal development and helps develop clinical reasoning and critical 
thinking. Smith, Brown, and Crookes, (2015) concur and additionally add that reflection 
allows the person to analyse the evidence and in so doing, creates new knowledge 
and experience. Creating this new knowledge is one of the corner stones behind the 
learning theory of Malcolm Knowles, The Four Principles of Andragogy, (Knowles, et 





Reflection is actively encouraged amongst health care professionals and there are 
many reflective models on which to base a reflective account (Kolb, 2015, Driscol, 
1994; Gibbs, 2008, 1988). With regards to nurses, reflection is now a crucial and 
mandatory element of their three-yearly revalidation with the Nursing and Midwifery 
Council (NMC, 2019). It was through reflection on my career, that I realised that it 
would be advantageous to undertake a university degree, in line with all newly trained 
nurses who qualified with either a degree or diploma. In in 2004, I was successfully 
awarded a BA (Hons) in Health Studies. 
2.3.1 Professional impact 
In 2002, I was appointed to a senior H-grade position as a lead Clinical Nurse 
Specialist working in hepatology and my success was attributable to my prior 
experiential learning (Kolb, 2015) and the fact I was undertaking a degree. Being 
awarded H grade status was an acknowledgement that I had entered the fifth and final 
stage of Benner’s (1984) framework of expert nurse status (figure 2).  
2.4 First publication 
In 2006, in recognition of my extensive input into anaesthetic research projects from 
1998 to 2002, I was placed as first author on the published research findings titled, 
“Perioperative Nimodipine and Postoperative Analgesia” (Casey [Mortimore nee 
Casey] et al., 2006). The hypothesis of this research was that Nimodipine, a calcium 
channel blocker would enhance the antinociceptive properties of Morphine therefore, 
prescribing patients nimodipine pre- and post-operatively would reduce overall pain. 
This would be confirmed by improved pain scores and a reduction in overall post-
operative Morphine consumption. Interestingly, the findings demonstrated that 
although there were no significant differences in pain scores between the groups 





Nimodipine there was increased Morphine consumption after 12 hours. This 
suggested that in patients receiving knee replacement surgery Nimodipine had no 
additional analgesic effect and, in contrast to the hypothesis, may inhibit the analgesic 
effect of Morphine. 
According to Sandercock, (2012) research findings suggesting no effect or opposite 
effect are deemed negative results and according to Dwan, et al., (2013) and Fanelli, 
(2012) negative results appear to be not published; estimated to be approximately 
50% of all published articles, or selectively published thereby introducing bias towards 
specific aspects of the study. Smith (2006) argued that the editorial peer review 
process is strongly biased against `negative studies' and is the reason why 
researchers do not publish their findings. Selectively publishing can cause huge issues 
in relation to evidence-based medicine, as HCP’s and policymakers making decisions 
on treatment and/or writing guidelines based on flawed evidence could cause serious 
harm. In comparison, the benefits of publishing results that contradict the hypothesis 
can help other researchers to adapt their research methods to increase their chances 
of success (Mlinarić, et al., 2017). 
2.4.1 Professional and Research Impact  
My lack of appreciation regarding the significance of being a published author 
highlighted my advanced beginner (Benner, 1984) understanding to research. At the 
time, although delighted of having my first publication, it did not occur to me that we 
may be advancing that field of research (Kelly, Sadeghieh, Adeli, 2014; Rawat and 
Meena, 2014). To date this article, “Perioperative Nimodipine and Postoperative 
Analgesia” has been cited sixteen times (Casey et al., 2006) in national and 





Although this article was not related to liver disease, the publication ignited my interest 
and enthusiasm for academic research. This article was pivotal, as it heralded a 
paradigm shift (Kuhn, 2012) in the nascent inception of my critical thinking and gave 
me the inspiration to expand my nursing and medical knowledge and the confidence 
to write articles for publication in peer reviewed journals, showcasing my expert 
knowledge in the field of liver disease. Moreover, it taught me that if the findings 
contradicted the hypothesis, it is still important to publish and disseminate, to aid other 
researchers in that field. 
2.5 Data collection 
In the 1990s and early 2000, academic nurse research was not high on the nursing or 
local National Health Service (NHS) agenda, although attempts were being made to 
redress the balance (DOH, 2012; UKCRC, 2007). These reports clearly outlined the 
barriers for nurses trying to undertake research such as: “clinical workloads…, an anti-
academic culture in the nursing profession……… lone working, poor appraisal 
systems and very limited education and training opportunities”. In addition, the report 
noted that “nurse researchers were unlikely to be supported by academic departments 
of nursing, if the work was under the command of other health professionals” (UKCRC, 
2007, pg. 17, 18). Instead, based on my expert knowledge I developed an appreciation 
of how knowledge could be developed, or noted gaps in knowledge that could be 
investigated to benefit patients, carers and HCPs and I commenced collecting relevant 
data for potential audit and research. This is supported by Cottrell (2017, P4) who 
states that “advances in knowledge and professional practice are made through 
recognising where improvements can be made to what has gone before.” In relation 
to nursing, skills through experience, are a prerequisite for becoming an expert nurse 





Collecting data sets was attributable to my desire and curiosity for knowledge and 
skills for use in clinical practice (Knowles et al., 2015). The collated data was pivotal 
in the following research Rye et al., (2016); Rye, et al., (2012); White, et al., (2011); 
Li, et al., (2006a, 2006b). 
The data was utilised in the prospective audits (Li et al., 2006a, 2006b) examining liver 
biopsy practice, related adverse events and patient usage of post-operative analgesia. 
The findings were published in the Journal of Hepatology which in 2019, had an impact 
factor of 20.582. 
2.5.1 Purposive sampling 
Data gathering is crucial in research and in the prospective audits Li et al., (2006a, 
2006b), and in the retrospective study, White, et al., (2011) purposive sampling 
techniques, a form of non-probability sample was chosen (Etikan, Musa and Alkass, 
2016). These patients were specifically selected because they were either undergoing 
a liver biopsy or they were homozygous for the H63D variant of haemochromatosis. 
According to Patton (2014) focussing on the similarity of the participants allows 
researchers to generalise the findings from the evidence gathered. However, it could 
be argued that by using homogenous purposive sampling it is too subjective and there 
is an element of researcher bias in choosing specific subjects for the study (Braun and 
Clarke, 2013). (Please see Chapter 4.1, for additional comments regarding the Li et 
al., 2006a, 2006b, White, et al., 2011 and Rye et al., 2012 publication authorship). 
2.5.2 Professional impact 
The recognition of where improvements could be made to patient care, also known as 
critical thinking (Kuhn 2012), allowed me to deliberate what data could be collected, 
as evidenced in the above studies, which had a positive impact on patient care. 





transitioned through the competent stage and was now proficient with regards to 
research (figure 2). 
2.5.3 Research impact 
These audits were published in eminent international journals for worldwide 
dissemination thereby contributing to the body of research and evidence-based 
medicine. Additionally, they were presented at the annual British Society of 
Gastroenterology meeting allowing dissemination of the research thus increasing my 
academic reputation. 
This research changed medical practice and improved patient care within the 
University Hospitals of Derby and Burton Foundation Trust (UHDBFT). The 
prospective audit of liver biopsies by Li et al., (2006a, 2006b) noted a reluctance by 
radiologists to use a wider bore liver biopsy needle because of the possibility of 
adverse events such as haemorrhage (O’Neil Machado, 2011). The findings of this 
research revealed that not only did the larger bore needle provide superior histological 
samples for analysis, but the smaller gauge needle gave samples that were often 
inadequate for assessment. This meant that some patients required a further liver 
biopsy to confirm a diagnosis which increased their risk of complications. In addition, 
it was reasonably postulated by some medics that using a larger gauge biopsy needle 
would cause increased postoperative discomfort and adverse events compared to 
using the smaller gauge needle. In contrast, the audit revealed that there was no 
statistical difference between the two groups regarding post-operative pain or adverse 
events. These findings changed radiology practice in UHDBFT, who now opt to use 
the larger gauge needle, giving improved histological samples and reducing the risk 





In the White, et al., (2011) study we examined patients who were diagnosed as H63D 
homozygotes over a 4-year period. H63D homozygotes for genetic haemochromatosis 
are noted to carry a small risk of developing iron overload compared to C282Y 
homozygotes. Therefore, H63D homozygotes are often not given long term medical 
follow up (Kelley et al., 2014; EASL, 2010) and in France, H63D genotyping is not 
requested (Fitzsimons et al., 2018).  
The findings revealed that 38% of H63D homozygote patients were histologically 
proven to have iron overload on liver biopsy. The study concluded that iron overload 
is still encountered in clinical practice and not related to an increase in ferritin due to 
an acute reactant phase and should therefore not be discounted. The results of the 
study led the hepatology unit to advise that all H63D homozygote patients, who do not 
require immediate venesection, to donate blood via the blood transfusion service and 
have ferritin and transferrin saturation levels checked yearly to two yearly by their 
general practitioner, with suggested referral back to secondary care if ferritin levels or 
transferrin saturation levels increase despite blood donation. This was in contrast to 
advice given in EASL (2010) haemochromatosis guideline. 
2.6 Advanced Clinical Practitioner 
Benner’s nursing theory (1984) proposes that over time, with experiential learning and 
appropriate education, nurses develop expert skills and understanding of patient care. 
This is evidenced within my own personal journey. After completing my MSc in 2010, and 
Leadership and Management course in 2011, my role as a nurse specialist developed 
further into an advanced clinical practitioner (ACP). Advanced clinical practice is 
defined by Health Education England (HEE) as “… a level of practice characterised by 
a high degree of autonomy and complex decision making………underpinned by a 





After hearing multiple accounts of poor experiences from patients undergoing 
therapeutic paracentesis, I recognised the requirement to improve the service and 
patient care offered to this group of patients. After approval from the hospital audit 
department, I devised my own audit and employed the findings to author a business 
case for a nurse-led paracentesis service.   
The business case proposed that if my nursing team undertook the paracentesis 
procedure rather than junior doctors, it would improve the patient journey and 
potentially save the Trust tens of thousands of pounds a year in inpatient overnight 
stays, save doctors time, and allow patients if medically fit to be discharged on the 
same day. This business case was presented to the senior management of the local 
Trust and approval was immediately given to set up and manage a nurse led 
paracentesis service after appropriate training. 
2.6.1 Professional Impact 
Cottrell’s (2017) acknowledges that recognising where improvements are required, 
advances knowledge and practice. LoBiondo-Wood, Haber and Titler, (2019) concur, 
and supported by reports from Titler, (2014) and Strauss et al., (2019) who state that 
the thoughtful use of current evidence combined with clinical experience and patient 
ideals, where appropriate, can guide health care decisions. It has been further 
recognised by Lunenburg, (2010), that any individual who initiates and manages 
change within an organisation is known as a ‘change agent’. Orchestrating and 
managing the paracentesis service to benefit the service users, based on collated 
evidence, clearly demonstrates that I was a ‘change agent’, a leader and highlighted 
my critical thinking, aptitude, and interest to improve evidence-based practice thereby 





expert level (figure 2) demonstrating all four pillars of advanced practice: clinical, 
leadership, research and education (HEE, 2017). 
2.7 Reviewing the literature 
Healthcare decisions for patients should be informed by the best available research 
evidence (LoBiondo-Wood, Haber and Titler, 2019; Strauss, et al., 2014) and this 
integration of the best available evidence, clinical expertise and patient values is 
termed evidence-based medicine (EBM). To ensure that EBM is delivered to a high 
standard, it is necessary for HCPs to keep abreast of new clinical evidence. According 
to Aveyard, Payne, and Preston (2016) and Gopalakrishnan and Ganeshkumar 
(2014), reading clinical guidelines and systematic reviews are a robust approach to 
assuring this practice. 
In the review article titled, “Towards non-invasive detection of oesophageal varices” 
(Rye, et al., 2012) a review of the literature was undertaken to examine and compare 
non-invasive ways to detect oesophageal varices, as opposed to the Gold standard of 
oesophago-gastro-duodenoscopy (OGD) in cirrhotic patients (Tripathi, et al., 2015). 
The review reflected on the dependability of different screening tests. Current 
guidelines recommend that all cirrhotic patients are screened for varices at diagnosis 
and followed-up either annually, or two to three yearly depending on size of varices 
and requirement for prophylactic medical treatment (EASL, 2018).  
Routine surveillance causes a huge burden on endoscopy units and regular OGD’s in 
some patients, can have a detrimental effect on compliance (Garcia-Tsao, et al., 2007; 
Merli, Nicolini, Angeloni, 2003). Moreover, Rye et al., (2012) acknowledged the 
variable inter-observer reliability for agreeing the presence and grading of the size of 
oesophageal varices at endoscopy and this was demonstrated by a large variation in 





to evaluate the quality, accuracy and trustworthiness of research processes and 
findings, in order to avoid misleading those that wish to utilise the research (Roberts, 
Priest and Traynor, 2006).  
The clinical review by Rye et al., (2012) concluded that despite the availability of 
clinical, radiological, and novel biochemical markers as a non-invasive means to 
diagnose varices, none were accurate enough to avoid endoscopy. Therefore, this 
review resulted in the confirmation that endoscopy remains the Gold standard 
screening tool for diagnosing varices despite its recognised limitations such as the 
cost to the NHS and unpleasantness for the patients.  
2.7.1 Research Impact 
This review assimilated and summarised the best available evidence which, according 
to Aveyard, Payne and Preston (2016) makes it valuable.  Although this article did not 
highlight a non-invasive test comparable to OGD it did recommend that further 
research into this area was required. Since its publication, it has been cited forty times 
in national, European, and international medical journals evidencing the impact and 
quality of this review (appendix 2). 
2.8. Non-invasive Diagnosis of Oesophageal Varices  
Following on from the Rye et al., (2012) review article, I was involved in further novel 
prospective medical research, investigating non-invasive means of diagnosing 
oesophageal varices measuring systemic haemodynamics by Finometry, compared 
with other non-invasive predictive scores (Rye, et al., 2016). Although the aim was to 
assess if the Finometer, as a non-invasive means was accurate in predicting varices, 
it required all patients who consented into the trial to undergo invasive endoscopy and 
portal pressure measurements assessed by measurement of the hepatic venous 





inserted to pass through to the superior vena cava until it reached the hepatic vein of 
the liver.  
In the Rye et al., (2016) study, a Swan-Ganz catheter was required to pass through 
the heart to reach into the inferior vena cava then into the hepatic vein. Once in the 
hepatic vein, rather than one measurement being taken, a minimum of three hepatic 
wedge pressure readings were taken and averaged. This was crucial to the accuracy 
of the study and ensured the reliability and validity of the wedge pressure 
measurements.  
According to Spieth, et al., (2016) and Wunsch, Linde-Zwirble and Angus (2006), 
choosing the appropriate study design is pivotal to produce accurate data that can be 
translated into clinical practice. The Rye, et al., (2016) study, the methodology and 
methods were clearly defined ensuring the research was reproducible, thereby 
improving its validity. However, it was acknowledged that larger studies were required 
to include patients independent of their prescribed medication and co-morbidities to 
validate the research findings.  
Selecting the correct statistical method is of paramount importance in quantitative 
studies as the inappropriate use of statistical techniques may lead to erroneous 
conclusions, which would undermine the significance of the findings within a research 
study. These findings would not only be misleading but could be construed as 
unethical or lead to unethical practice (Ali and Bhaskar, 2016; Sprent, 2003). 
Therefore, the correct statistical analysis is part of the rigour in the validity and 
reliability of quantitative research studies. In the study undertaken by Rye, et al., 





The patient cohort groups were split into two groups. Group One, diagnosed with 
absent or small varices, N=18 and Group Two, who were diagnosed with medium to 
large varices, N=11. The OGD were undertaken by an experienced endoscopist who 
classified the size of the varices. The classifications were confirmed by a second 
clinician who observed the procedure to verify the results thus, increase reliability and 
validity and reduce bias. The differences between Groups One and Two were 
compared using a Mann-Whitney Test and associations between the variables was 
assessed by the Spearman correlation coefficient. The statistical analysis was 
undertaken using Analyse-It for Microsoft Excel (version 2.21). P values of less than 
0.5 were considered statistically significant. Findings revealed that there were 
significant associations with Child Pugh score, cardiac output, cardiac index, hepatic 
venous pressure gradient and peripheral resistance with large oesophageal varices. 
2.8.1 Research Limitations 
Limitations of the study research were clearly articulated in the Rye, et al., (2016), 
however, this was with hindsight, after study completion. The study acknowledged 
conditions that would affect systemic haemodynamics, such as the existence of 
hypertension or prescription medications, which occur frequently in the general 
population, but were excluded, potentially limiting the applicability of the test to a wider 
population, hence population bias (Gola, et al., 2020; Pannucci and Wilkins, 2010). In 
addition, patients who consented underwent invasive procedures; they were required 
to have an additional endoscopy to confirm size of varices as well as undergo a neck 
vein puncture with the associated risks of haemorrhage and haematoma formation 
and the added risk of heart arrythmias during the procedure. As only twenty-nine 
patients consented for the study it was acknowledged that larger prospective studies 





probes required to undertake beat-to-beat measurements as opposed to cheaper non-
invasive tests may deter its widespread use across NHS Trusts. 
2.8.2 Ethical considerations 
The ‘Non-invasive Diagnosis of Oesophageal Varices Using Systemic Haemodynamic 
Measurements by Finometry: Comparison with Other Non-invasive Predictive Scores’, 
Rye et al., (2016) study required patients who consented to participate to undergo 
invasive procedures as discussed in chapter 2.8. Any research study requires all 
potential risks to be explained to the participants and written, informed consent to be 
taken. All patients who consented to participate in this trial were fully aware of the 
invasive nature of a neck puncture, the possibility of developing cardiac arrythmias or 
haematoma formations in the neck and the requirement of an additional OGD. It is 
widely acknowledged that informed consent requires patients to receive appropriate 
and accurate information regarding the study in a language that is easily understood 
for any potential participant and complies with data protection law (Dankar, Gergely, 
Dankar, 2019; Information Commissioner’s Office 2018; Chan, et al., 2017).  
I was well known to the hepatology patients and well liked. An ethical consideration 
was that I had to ensure that my relationship with the patients did not unduly influence 
their decision to join the research trial. This was resolved by not allowing patients to 
sign up for the study immediately but instead were provided with an information sheet 
to share with their loved ones. After seven days, they were approached by a different 
researcher, given the opportunity to ask questions and if they were still willing to 
participate in the study, the consent form was signed.  
All research studies undertaken within the Trust including the Rye et al., 2016 had to 





English research committee as well as be approved by the local hospital ethics 
committee before the research could commence. 
2.8.3 Professional Impact  
Personally, it was a privilege to be involved in pioneering medical research. I gained 
experience in the use Swan-Ganz catheters to obtain hepatic wedge pressures. My 
clinical expertise as a nurse and prescriber came to the fore when three patients 
developed supraventricular tachycardia and I prescribed and administered 
intravenous medication to correct this, after first initiating vasal vagal manoeuvres to 
slow down their heart rate (ACLS, 2020; Smith, 2012). Being pivotal in medical 
research studies demonstrated my development into a proficient researcher according 
to Benner’s framework (1984) (figure 2) and instilled confidence to consider 
undertaking my own research study. 
2.8.4 Research impact 
The findings suggested that using Finometry could identify cirrhotic patients that do 
not require endoscopic surveillance for varices, thereby lessening the burden on 
endoscopy units. The results also suggested that Finometry had an improved 
diagnostic value than other non-invasive markers such as platelet count or Child-Pugh 
score; a scoring system to measure the severity of liver disease.  
2.9 Genetic haemochromatosis: a qualitative exploration of patients’ 
experience of diagnosis, treatment and management 
My many years of treating patients with haemochromatosis allowed me to hear their 
personal stories of the time it took to be diagnosed with the condition and the anxiety 
that this diagnosis caused them, especially when informing other close family 
members. Listening to the patient voice was the primary reason that I undertook 





haemochromatosis. Despite the prevalence of genetic haemochromatosis, only 
1:5000 people are diagnosed with the condition in the UK (HUK, 2019; BLT, 2017). 
However, once diagnosed, treatment is lifelong. To date, there is a paucity of research 
examining patients’ thoughts and experiences of being diagnosed with 
haemochromatosis and the effect this may have on their lives and immediate family.  
2.9.1 Study design and methods 
The aim of the study was to explore patient perceptions, perspective, and experiences 
of those living with genetic haemochromatosis; including how and when they were 
diagnosed. This was to ascertain how and when patients were first diagnosed with the 
condition, the effect of their diagnosis on their ontological security, their experience of 
living with the disease, the effect if any, on their family or loved ones as well as 
examining the patients’ experience of receiving treatment.  
Purposive sampling was employed to recruit participants from the local hospital. All 
participants volunteered after responding to a poster advertising the research study.  
Data was collected from twenty-four patients using semi-structured interviews, using 
broad themes. The interviews were recorded and transcribed verbatim. This was 
analysed using thematic analysis.  
2.9.2 Emerging themes around diagnosis 
Two themes emerged from the interview process around the participants diagnosis. 
The first was regarding the length of time it took for a diagnosis to be made and the 
second was the perceived lack of knowledge and information given about the condition 
from the GP. These findings were articulated in an academic poster (Mortimore and 
Woodward, 2019), (figure 3), and exhibited at the Royal College of GPs annual, three-





Figure 3: Genetic haemochromatosis: a qualitative exploration of patients’ experience of 
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diagnosis. Presented at RCGP annual conference in October 2019. Authored by Gerri Mortimore 
and Amelia Woodward. 
By doing so, highlighted the findings to several thousand attending GP delegates. This 
led to academic discussion with GP’s, establishing that there was a consensus of 
agreement with the conclusions, thereby improving the study’s validity and reliability 
of the findings.  
Presenting quotations as exampled below (figure 4) and those in the poster presented 
to RCGPs (Mortimore and Woodward, 2019) provided further evidence which 
supported and validated the findings (Miles and Huberman 1994; Gibbs 2008; Patton, 
2014). 
 
Figure 4:  Direct quotes from patient transcripts 
“….      ’                         
           ….                     
bit of confidence when you are 
watching them read Google in 
front of you as to what it is. And I 
know they probably have the 
background and maybe they have 
got more that they can access but I 
    ’                              
that she just handed me over. 
              ’              
because his knowledge about 
the subject, because I know I 
went back about something else 
and I said to him, oh by the way I 
have  got this 
                …… “    






According to Tobin and Begley (2004) the application of scientific accuracy in 
qualitative research supports reliability and competence. However, in contrast to this 
Sandelowski (1997) argues that rigour in qualitative research could supress creativity. 
Thomas and Magilvy (2011) concur with this point, adding that rigour implies 
inflexibility and qualitative research is not rigid in design. It is recognised that 
qualitative research can be challenging to undertake as there are no accepted 
consensus regarding guidelines by which the research can be judged.  
Bias can occur at any time throughout the research process. As the researcher plays 
such an active role in the research, there is always the risk that their individual beliefs 
and values may over influence the data collection and analysis and the research 
findings could be argued as a collection of the researcher’s opinions (Papp, et al., 
2014), also known as insider or researcher bias (Greene, 2014).  To avoid this, and 
certainly, pertinent to my qualitative research study “living with genetic 
haemochromatosis” (Mortimore and Woodward, 2019) the interview questions were 
open ended, to allow the interviewee to freely communicate without coercion (Mannix 
and Jones 2020; Braun and Clarke, 2013; Guest, McQueen and Namey, 2012). As I 
was the principal investigator, I was the interviewer in all the interviews. However, 
because of my interest in the subject of haemochromatosis, I could argue that although 
concerns could be raised regarding insider bias, my knowledgebase enhanced the 
study by allowing a greater insight into the phenomenon being studied. However, to 
minimise bias, all interviewees were invited to listen to the recorded interview, or read 
the typed transcriptions, with a different experienced researcher from the University 
research department. The interviewees could delete anything they did not agree with 





2.9.4 Professional impact 
It is an achievement to undertake research from its conception; where I recognised 
the importance of listening to patients’ concerns and felt empowered to change this 
for them.  
As with all medical research studies the “living with genetic haemochromatosis” study 
required the completion of the Integrated Research Application System (IRAS) and 
after its successful completion, which required national ethical approval (appendix 3) 
local NHS trust ethical approval was sought and granted for this study. As the initial 
findings (Mortimore and Woodward, 2019) demonstrated a lack of perceived GP 
knowledge, this led HUK to organise UK wide GP webinars, which I personally 
present, adding to the dissemination of my research to health care professionals. 
2.9.5 Research impact 
The Mortimore and Woodward (2019) study identified that patients perceived gaps in 
GP’s knowledge about haemochromatosis, its diagnosis and treatment. Ensuring that 
GPs are aware of genetic haemochromatosis and the strategies to diagnose the 
condition earlier can lead to improved patient care and lessen the long-term burden of 
chronic liver disease on NHS Trusts. The findings from this research study pathed the 
way for formal teaching sessions for GPs to be undertaken. Due to Covid-19 
restrictions these teaching sessions were undertaken as live webinars, the content of 
which was to highlight early and late symptoms of haemochromatosis, the importance 
of the correct diagnostic tests and treatment as well as highlighting the preliminary 
findings from Mortimore and Woodward (2019) study. The highlighted fact that GPs 
knowledge of the haemochromatosis was poor has been used as evidence by HUK, 
and continuous professional development (CPD) teaching sessions, via the RCGPs’ 





the strategies for diagnosis. Moreover, the findings from this study were presented to 
Parliament in February 2020. 
2.10 Peer review 
Within the academic and scientific community, peer review is an essential element of 
the writing process and is an effective form of research evaluation to help select the 
highest quality articles for publication (Kelly, Saneghieh, Adeli, 2014). All the 
publications within this thesis were submitted for double blind peer review, prior to 
publication (Casey et al., 2006; Li et al., 2006a; Li et al., 2006b; Rye et al., 2016; Rye 
et al., 2012; Watson and Mortimore, 2019; Mortimore, 2018d; 2017b, 2017c, 2017d), 
NICE website (NICE [QS152] 2017; NICE [CG50] 2016; NICE [CG188] 2015a; NICE 
[QS104] 2015b; NICE [CG100] 2010).  
2.11. Research Philosophy 
Embarking on my research journey in the late 1990’s, little thought was given to the 
underpinning research philosophy of the medical studies However, I now appreciate 
how my beliefs, assumptions influenced the chosen research strategy and 
methodology of the research being undertaken. In Casey et al., (2006); Li et al., 
(2006a); Li et al., (2006b); Rye et al., (2016) a deductive approach was utilised, which 
falls under the positivist paradigm, associated with scientific research (Crossan, 2003). 
These studies investigated facts such as portal pressure measurements (Rye et al., 
2016), pain scores and morphine consumption (Casey et al., 2006); biopsy needle 
size, pain scores and analgesic consumption (Li et al., 2006a; Li et al., 2006b) and 
tested hypotheses that emerged from those theories. As my understanding and insight 
of research developed, I realised when listening to patients views and anxieties, that 
from my own epistemological concerns, the medical research we were undertaking 





In the “Living with genetic haemochromatosis” study (Mortimore and Woodward 
2019), I explored the perceptions of patients living with haemochromatosis. I believed 
that phenomenology was the most suitable approach to this research as 
phenomenology seeks to describe the phenomenon by exploring it from the 
perspective of those who have experienced it (Manen, 1997). According to Laverty 
(2003), by examining subjective experiences, new meanings can be developed to 
inform how we understand that experience. From my personal axiological viewpoint, I 
placed great value on social interaction thus, interviews were my preferred method as 
they could provide a richness of data regarding patients views than an anonymous 
questionnaire. This understanding of research philosophy enabled me, as a 
researcher, in the later research of Francis, Mortimore and HUK, (2020) and 
Mortimore and McClements (2020; 2020a), to choose the most appropriate 
methodology and methods, changing to a Pragmatic approach. This will be discussed 
further in chapter 3. 
2.12 Reflection 
This chapter evaluated my research contribution and how this influenced my 
professional standing.  It also evidenced how my published research has added to the 
body of knowledge in the form of EBM, and as such, is advancing health professionals’ 
knowledge of liver disease. This knowledge assists to improve the standards of 
medical and nursing care for patients receiving treatment for liver disease. Reflecting 
on my research philosophy, I am one of a few researchers who has undertaken 
quantitative medical research under the positive paradigm and, after listening to 
patient experiences, undertook qualitative research under the interpretivist paradigm. 
The knowledge gained from both was utilised to undertake research under the 




























Chapter 3: Theme 2 - As an influencer of national policy 
The previous chapter provided an overview of how my career and experiential 
research knowledge shaped and developed me from a novice nurse researcher into 
nurse expert within the field of hepatology. This chapter demonstrates how my 
research and expert knowledge has been utilised as a platform to advance health 
professionals’ knowledge of liver disease and influence the public through my 
contribution to national guidance and direct dialogue with Government. A significant 
impact of this body of work has been raising the profile of liver disease on a national 
and international level.  
3.1 Researcher Goal 
A goal for any researcher is for their expertise and research findings to be used to 
inform and influence local, national, and international policy (Ellenbecker and Edward, 
2016). In relation to the field of health and social care, informing and influencing policy 
may in turn improve, or even transform lives for the better. Although it is recognised 
that health policies are regularly developed, Wakefield (2009) acknowledges that 
these polices are frequently written and implemented without the evidence of research 
conducted by the nursing profession. The Institute for Government, the leading “think 
tank” which explores key challenges facing government, goes further to state that 
although academic evidence and expertise can inform and improve government 
policy, many academics find engaging with policy making, difficult and as a result, 
policy influence is often limited (Sasse and Haddon, 2019). Arguably, little has 
changed over the last twenty years as evidenced by Gough and Walsh (2000) and 
Hart (2004), who suggested that it was difficult for nurses to be seen as credible in 
strategic policy making. However, in contrast to these findings, I will evidence how my 





Government and authored reports which have been shared with not only the English, 
Northern Ireland, and Welsh Parliamentarians but also the Scottish Government and 
UK Blood Transfusion Service (BTS). 
3.2 NICE Guidelines  
Over the last forty years, the UK has witnessed over a 400% - 500% increase in 
mortality caused by liver disease, whereas death rates from other diseases have fallen 
(Williams et al., 2018; PHE 2018; Williams et al., 2015). This factor highlights liver 
disease and its treatment as an essential area for HCPs, Clinical Commissioning 
Groups and NICE to utilise evidence-based medicine to inform and advance care in 
these areas.  
Clinical guidelines are born out of the systematic review of relevant and best available 
research literature which is paramount to avoid biased results (Polit and Beck, 2014; 
NICE, 2020a). This research evidence is assessed, examining both the harms and 
benefits of treatment options, clinical effectiveness, and projected economic 
implications, with recommendations intended to optimise patient care (Kredo et al., 
2016). Although Murad (2017), acknowledges that although guidelines are intended 
to improve patient care, guideline adherence is variable.  
An integral component of NICE clinical guidelines is the advice and guidance from the 
invited health care experts involved in the topic. My expertise within the field of liver 
disease (as evidenced in Chapter 2) enabled me to be successfully selected as a 
member of the expert panel in the following guidance.  
• Alcohol Misuse Disorders (CG 100, 2010) 
• Gallstone disease (CG 188, 2015a)  





In recent years, the increasing importance of systematic literature reviews in health 
and social care, to inform evidence-based clinical practice and health care has been 
acknowledged (Aveyard, Payne, and Preston, 2016; Polit and Beck, 2014; Bowling 
2014). As evidenced, systematic literature reviews are an essential process in NICE 
guidance (NICE, 2014) and as such, NICE employ professional researchers to 
undertake this work. Whilst being involved in devising NICE guidance it became 
apparent that the reviewers were often not from a health background. Occasionally, 
the reviewers used incorrect or inadequate search terms. Our remit, as part of the 
expert panel was to review the search terms to minimise error; suggest published 
research, or research imminently about to published, or seminal published research 
which fell outside the “year” search parameters.  
3.2.1 Professional Impact 
NICE guidelines offer recommendations for the treatment and care of patients in 
England and Wales, based on the best available evidence thus, improving outcomes 
for patients, whilst ensuring efficient use of healthcare resources.  
My many years of experience within the field of hepatology as well as my involvement 
in collaborative medical research led to my successful appointment as an expert 
advisor in NICE Clinical Guidelines. In addition, in October 2020, I received a formal 
letter of appreciation from NICE regarding my contribution of time and expertise into 
the development of the cirrhosis surveillance report, stating that my contribution 
informed NICE’s decision to update the NG50 guideline (NICE, 2016). The 
recommendations for an update have now been published on NICE’s website and 






My expert influence in developing NICE Guidelines means I have assisted in 
standardising the level of service delivery of care across England and Wales, enabling 
a patient centred approach to health care. I have used this knowledge to educate 
HCP’s, within an HEI, knowing that by doing so, I am contributing to evidence-based 
medicine. 
3.3 Quality Standards 
In addition to my involvement in devising three national guidelines I assisted in 
developing NICE Quality Standards (QS) in:  
• Liver disease (QS 152, 2017)  
 
• Gallstone disease (QS 104, 2015b)  
QS set out priority areas for quality improvement for health and social care and cover 
areas across England and Wales where there is a disparity in care. Each standard 
consists of prioritised measurable statements designed to support the measurement 
of improvement. QS are intended to improve the quality of care offered, although it is 
accepted that this may not always be appropriate in practice (NICE, 2020a) and 
consideration must be taken regarding professional judgement, safety, shared 
decision-making, and patient choice (NICE, 2020a; The Kings Fund, 2015). For 
example, regarding the QS on gallstone disease (NICE, QS 104, 2015b); quality 
statement 1: “Adults with acute cholecystitis will have a laparoscopic cholecystectomy 
within 1 week of diagnosis” (NICE, QS 104, 2015b, page 10). Due to the lack of 
operating department availability at the local NHS Trust, it was not possible to offer 
every patient admitted with cholecystitis a cholecystectomy within seven days of 





3.3.1 Professional impact 
By being directly involved in devising QS and through the implementation of my 
research, in particular Rye et al., (2016); Rye, et al., (2012); White, et al., (2011) and 
Li, et al., (2006a; 2006b). I have assisted in providing patients, carers, service 
providers and health care professionals with relevant definitions of high-quality 
healthcare directly related to liver and gallbladder disease.  
In addition, my involvement on the expert advisory panel, with published NICE clinical 
guidelines and QS, supports the Government’s vision on a health and care system 
focused on delivering best practice in patient care nationally (DHSC, 2012) and clearly 
demonstrates my direct impact on the outcomes of services being developed and 
delivered. It was because of my input into the three published NICE national guidelines 
and two Quality standards for England and Wales that I was formally awarded the title, 
“NICE Expert Nurse Advisor”, thereby confirming my expert status.  
3.3.2 Research Impact 
NICE Guidance and QS are freely available to download from NICE websites for HCPs 
and lay people.  They are referred to within all aspects of health care from primary to 
secondary care and community settings. NICE (2020b); DOH and PHE (2014) 
acknowledge that NICE publications influence national and international health policy. 
Consequently, being a member of the expert panels that devised NICE clinical 
guidelines and QS in liver disease, substantiates the fact that I have informed national 
and international policy. 
3.4 Venesection Best Practice Guidelines 
In 2017, as part of my on-going research activity, I contacted the charity, 
Haemochromatosis UK (HUK), to inform them of my proposed qualitative study 





With the patient voice in mind, I requested if HUK were satisfied with the planned 
themes I was proposing to explore from a patient perspective. According to the NIHR 
(2020) and Hørder, Konge and Nielsen (2020), patient insight into research design 
brings many benefits, including providing a unique awareness into living with the 
condition, highlighting points that may not have previously been considered to the 
researcher and helping to identify problem areas that potentially may be off-putting or 
restrictive for patient participation in the trial.  HUK were delighted to endorse my study 
and stated that any research that raised the profile of haemochromatosis was of 
benefit. 
It was because of HUK’s knowledge of my qualitative research study and my interest 
and expertise regarding GH, as evidenced by my published articles Mortimore 
(2017b); White, et al., (2011), that I was approached by the charity in 2018, to assist 
in devising venesection guidelines for the UK, where no such provision existed. These 
guidelines were several years in the making as it required evidence, obtained from 
nurses and patient experiences from across the UK and Ireland. Best Practice study 
dates were arranged in 2018 and again in 2019, to reach a consensus of what was 
considered good practice, in relation to venesection procedure and care. Comparisons 
of local venesection guidelines from around the UK, and additional data gathered at 
these study days highlighted that patient experience differed widely, which has serious 
implications for patient care and safety. These implications were dependent on the 
diversity of nursing care delivery, its commissioning, equipment used and 
environments for venesection, including blood disposal which varied around the 
country. The NMC Code (2018); Hallam, et al., (2016) and Loveday, et al., (2014) 
acknowledge that it is the health care professionals’ responsibility to ensure that each 





3.4.1 Professional Impact 
The Venesection Best Practice Guideline (VBPG), (Francis, Mortimore, HUK, 2020) 
address the shortfalls highlighted during the Best Practice Study Days and by listening 
to the patient voice, aim to improve the quality and safety of patient care and 
experience. Additionally, it demonstrated collaborative working with a national charity 
and has assisted in standardising the care of thousands of patients undergoing 
venesection every year not just haemochromatosis but polycythaemia; primary and 
secondary, and transfusion related iron overload. 
This guidance published in January 2020, was endorsed by RCN, signifying that it 
conforms to the RCN quality criteria for professional standards and is deemed suitable 
for national UK nursing practice (RCN, 2020). As the VBPG has this endorsement, this 
publication is permitted to use the RCN’s logo. 
This VBPG project won awards from two major organisations, the Patient Safety 
Learning and The Patient’s Association, working for the wellbeing of hospital patients. 
As cited in the University of Derby’s Press release on the 22nd June 2020, and 
reiterated in the Nursing Notes website, the venesection guideline is “a testament to 
the skill and thoroughness of the authors that this guide has now been endorsed by 
the Royal College of Nursing as a national best practice guidance……… and will 
benefit tens of thousands of patients every year” (appendix 4). 
In March 2021, my co-author and I were announced winners of the prestigious BJN 
Nurse of the Year Awards, 2021 (appendix 5). This evidences the importance of the 
VBPG as it not only standardises practise across the British Isles and Republic of 






3.4.2 Research Impact 
The VBPG (Francis, Mortimore, HUK, 2020) acknowledges the increasing 
importance of the use of evidence in informing standards of nursing care for patients 
undergoing venesection and furthermore, recognises the role of patients and HCPs in 
contributing to the body of evidence to enable sustainable improvements in quality and 
safety of patient care. 
The guideline is available from all RCN libraries and most academic and public 
libraries within the UK and Republic of Ireland. It is freely available to all health care 
workers and patients worldwide, by being distributed through a global organisation in 
Amazon. This impact clearly evidences how this work is advancing HCPs’ knowledge 
of liver disease within a national and international arena. 
3.5 Research Dissemination 
According to Bowling (2014), dissemination of research findings is essential for health 
service development and researchers have a duty to ensure their findings, either 
negative or positive, should be disseminated. Presentations at key meetings and 
conferences and publications in appropriate journals are likely to be accessed by 
target audiences.   
In recent years, in recognition of my research reputation, I have been invited to speak 
at numerous national conferences on liver disease and nurse leadership. My first 
national conference was in 2012 and since 2018, I have spoken at thirteen national 
and local conferences; disseminating, informing, and increasing health professionals’ 






3.6 All Party Parliamentary Group and Freedom of Information Report 
My continued interest in genetic haemochromatosis, through published papers 
(Mortimore 2017; White, et al., (2011), including the addition of a poster presentation 
at the Royal College of General Practitioners’ Conference in 2019 (Mortimore and 
Woodward 2019) and involvement with the VBPG (Francis, Mortimore, HUK, 2020), 
led to an invitation from HUK to become an expert nurse advisor to an All Party, 
Parliamentary Group (APPG) on haemochromatosis. To this end, I was requested to 
write a preliminary report on the findings of Freedom of Information (FOI) requests 
made to all UK Hospital Trusts regarding GH and included numbers of patients treated, 
if they possessed written guidance/protocols regarding diagnosis and venesection 
(Mortimore and McClements, 2020a). This report was verbally presented to the group 
of assembled Members of Parliament (MP’s) who attended the APPG in February 
2020, in Westminster. 
In September 2020, the final FOI report, “The State of the Nation” (Mortimore and 
McClements 2020), was published. This report gave details of NHS Trusts who did not 
respond to FOI requests despite it being a statutory requirement (FOI Act, 2000). It 
highlighted that 54% of Trusts do not use a protocol for venesection and 46% did not 
use a guideline to diagnose and treat patients with GH, despite guidelines written by 
Fitzsimons, Cullis, Thomas, Tsochatzis, Griffiths (2018), published in the British 
Journal of Haematology. More importantly, it emphasised that less than twenty 
thousand people are being treated for GH in the UK, when it is estimated from research 
undertaken from the UK Biobank that three hundred and eighty thousand people are 





3.6.1 Research Impact 
There were three target audiences for the “State of the Nation” report (Mortimore and 
McClements 2020). The first target audience was for people diagnosed with 
haemochromatosis to allow for transparency so they could view and compare how 
their Trusts compared to others around the UK. Thus, the report has been made freely 
available to all HUK members on their website.  
The second target audience was UK Parliamentarians, including those who formed 
part of the APPG. A copy of the report was sent to every MP in England, Northern 
Ireland, Scotland, and Wales to raise greater awareness about haemochromatosis 
and gather support to lobby Government and NHS Trusts for greater action regarding 
earlier diagnosis and treatment for haemochromatosis. This impact has been 
evidenced by a letter received from the Right Honourable Sir John Hayes (CBE) who 
submitted two questions to the Secretary of State for Health and Social Care regarding 
what steps the Department of Health will take to improve the early diagnosis for those 
suffering with haemochromatosis (appendix 7).  
The third audience was the Blood Transfusion Service (BTS). Sadly, the 
therapeutically venesected blood taken from patients in hospital is not used to make 
blood products, it is disposed of. HUK are lobbying the BTS to allow 
haemochromatosis patients more frequent venesections than normal practice, thus 
allowing their blood to be used towards blood products. This is of immense 
importance, as it increases blood product availability across the UK, reduces valuable 
blood wastage and makes it more convenient for people with GH to donate their blood 
at BTS rather than attend hospital appointments. This is a pertinent point during the 
Covid pandemic of 2020, where some patients were not allowed into hospitals for their 





In view of the diverse audience for the State of the Nation Report (Mortimore and 
McClements 2020, 2020a), the requested remit from HUK was for the report to be 
easy to read. Over recent years there has been wide debate, regarding the importance 
of avoiding medical jargon (Rimmer, 2014) and this sentiment has been reflected 
within academia (Lynch, 2018). Although simply written, the report did contain hard 
hitting facts in easy-to-understand text, tables, Pie and Bar charts demonstrating the 
disparities in care across the UK. These results were derived from respondents’ 
answers to the FOI questions and were populated into a excel spreadsheet so the 
data could be simply and quickly analysed.  
3.6.2 Professional impact 
This FOI report highlights that genetic haemochromatosis is a relatively common but 
underdiagnosed condition. By highlighting these important facts to MP’s across the 
UK, presenting the findings to Parliament and the BTS, and with letters from MP’s with 
questions to the Secretary of State for Health and Social Care regarding 
haemochromatosis, as well as requests to add additional blood tests to the NHS health 
check (appendix 10), clearly demonstrates that my research is being used to increase 
liver disease awareness and influence policy. This contradicts the earlier evidence 
presented by Gough and Walsh, (2000); Hart, (2004); Wakefield, (2004) and Sasse 
and Haddon, (2019) that nurse academics find engaging with policy problematic and 
are not seen as credible in strategic policymaking.   
3.7 Research Philosophy 
According to Dudovskiy (2016), pragmatists will use whatever research method is 
required or a combination of methods to find the answers to their research questions. 
Pragmatists solve problems in a practical, achievable, and sensible way rather than 





Venesection Best Practice Guidelines (Francis, Mortimore and HUK, 2020) involved a 
mixed methodology of qualitative and quantitative techniques; listening to health care 
professionals and patient views, documenting, and analysing the results as well as 
examining NHS hospital protocols on venesection, all contributed to the final guidance.  
Mixed methods were employed in developing the FOI, “State of the Nation Report” 
(Mortimore and McClements 2020, Mortimore and McClements 2020a) where 
answers to the FOI questions were entered into an Excel spreadsheet and simple 
analysis undertaken. Guidelines and protocols sent form various hospitals were 
collated and examined to ascertain on what research they were based on. In contrast, 
I chose qualitative techniques for the Living with Genetic Haemochromatosis study 
(Mortimore and Woodward, 2019) as this was the most appropriate method to explore 
patients’ perceptions of living with the disease, using in-depth recorded interviews, 
which offered a richness of data that could not be achieved by a simple questionnaire. 
The research design in the above studies were chosen as the most pragmatic way to 
address the research question with the ambition that the research findings would 
promote change and improve health care practice and care for patients worldwide. 
The chosen research methods within these studies (Mortimore and McClements, 
2020; Mortimore and McClements, 2020a; Mortimore and Woodward, 2019; Francis, 
Mortimore, HUK, 2020), allowed me to address the practical questions of my research 
in a flexible manner. 
3.8 Reflection  
Reflecting on my publications it is apparent that in some instances the research differs 
from findings from guidelines or other seminal published works. For example, the 
EASL (2010) haemochromatosis guideline does not advocate the long-term follow-up 





publication which looked at how many H63D homozygotes were diagnosed within a 
five year period in the local hospital Trust, discovered that 38% of patients 
homozygous to H63D genotype developed iron overload requiring therapeutic 
venesection. This was in contrast to papers published in 2016 by Rombout-
Sestrienkova et al., and Porto et al., where the authors state there is only a 0.5 – 2.0% 
risk of patients of this genotype to develop iron overload. EASL (2010) also state that 
H63D homozygosity does not cause iron overload and of note, France does not offer 
genotyping for this variant gene. 
This findings in the White et al., 2011 study determined that all H63D homozygotes 
who do not require venesection should have long term follow-up with their GP in the 
form of two to three yearly blood tests to check ferritin and transferrin saturation levels. 
Any abnormalities in these readings would necessitate a referral back into secondary 
care. The conflicting evidence that 38% of H63D patients developed iron overload, 
which goes against European findings clearly suggests that further research is 
required in this area. 
The report “State of the Nation” (Mortimore and McClements 2020a) asserted that 
there are approximately four hundred thousand people with genetic 
haemochromatosis within the UK: approximately one in one hundred and fifty in 
England and Wales and one in one hundred and thirteen in Scotland and Ireland. This 
goes against the evidence provided in the AASLD haemochromatosis guideline 
(Bacon et al, 2011) which state that it affects one in every two hundred to two hundred 
and fifty people. Again, further research is required, which I am hoping to be involved 





National guidance influences international health policy and improves the standards 
of medical and nursing care delivered to patients worldwide. Being involved in NICE 
guidance and quality standards as well as authoring Venesection Best Practice 
Guideline clearly demonstrates that I have added to the body of research knowledge 
and contributed to evidence-based medicine.  
In recognition of my research and publication outputs I was identified by the University, 
as a staff member with a Significant Responsibility for Research (SRR) and submitted 
to the Research Education Framework (REF) 2021 in November 2020. The principle 
aim of REF “is to secure the continuation of a world-class, dynamic and responsive 
research base across the full academic spectrum within UK higher education.” (REF, 
2020). Being part of REF, I was advised to publish in three star journals with 
international outreach. Although I have published in what is considered 3 star journals, 
for example the Journal of Hepatology with an impact factor of 20.5 and involved in 
national guidance, the majority of my informative articles have been published in 
nursing journals and therefore a dichotomy exists between impact and influence.  
Nursing journals do not have the impact factor of medical journals. This should not 
deem them of less importance. For example, the well know British Journal of Nursing 
(BJN) was noted to have an impact factor of 0.71 (BJN, 2021) but I would argue that 
by aiming my  articles at nurses, and bearing in mind I am a nurse, I am influencing 
my cohort group to make a positive difference in the care received by patients with 
liver disease. For every one doctor working in the NHS there are two and a half nurses, 
with the latest figures in 2020 reporting approximately three hundred thousand nurses 
in the UK (Department of Health and Social Care, 2020). Despite publishing in what is 





26.11, (appendix 8) when three months ago it was 25.92 (appendix 2) demonstrating 
my increasing research reputation. 
In 1982, as a novice nurse, I could not envisage that in the future I would contribute to 
national policy, write national guidelines, speak with Members of Parliament to attract 
attention to a medical condition, be involved in research, devise and undertake my 
own research studies, and be a published author of numerous articles. Likewise, when 
Benner wrote about “From Novice to Expert” nearly forty years ago, she too would find 
it difficult to predict the future transformation of nursing and how nurses can not only 
reach her “Expert” status but can transcend beyond this point. This will be discussed 

















Chapter 4: Theme 3 - As academic/practitioner delivering best practice 
in the clinical setting. 
The previous chapter evidenced how my professional and research impact, advanced 
HCPs’ knowledge of liver disease on a national and international level. This 
achievement in my personal career did occur suddenly but developed over time, as 
my experience, confidence and competence grew, following Benner’s novice to expert 
(1984) framework. The Derby Model (Mortimore et al, 2021), (figure 2), evidence how 
my advanced clinical competence, expertise and research in hepatology has now 
exceeded this level of expert.  
Since 2006, my collection of published works, integrating three differing paradigms of 
positivism, interpretivism and pragmatism shaped and developed me from a novice 
nurse researcher to an internationally recognised researcher and policy influencer 
(figure 2) within the field of hepatology. During the late 1990s and 2000s the medical 
research I undertook was under the auspices of my medical colleagues, as my 
experience and confidence grew, I worked alongside them as a peer and advised what 
audit and research they could undertake, to finally undertaking my own qualitative and 
mixed methods research, without medical input. This latter research has informed 
policy and led guidelines being produced for the UK.  
This chapter explains how my collection of published research and academic articles 
assisted in advancing health professionals’ knowledge of liver disease and 
strengthened my research reputation, supported by my ResearchGate score. 
Additionally, I discuss how this increased reputation attracted attention from 
international pharmaceutical companies seeking advice on research into 






Mortality and morbidity from liver disease has witnessed an unprecedented increase 
over the last four decades. The complex nature of end stage liver disease highlights 
the importance of advancing HCPs’ knowledge of the subject. The dissemination of 
my research findings and published academic articles regarding the differing types of 
liver disease adds to the body of EBM and allow HCPs to make informed decisions 
that will ultimately lead to improved patient outcomes. 
My data was pivotal in the audit in the prospective and retrospective published audits 
undertaken in the 2000’s namely: White et al., (2011) and Li et al., (2006a, 2006b). To 
add clarity to my role in these publications, they could not have been authored without 
the data I had painstakingly collected, collated, and freely offered to the hepatology 
research registrars. Disappointingly, when another doctor was asked to assist to write 
the article, I was never considered to author alongside them, and as such, my name 
was moved from second to third position as noted in the White et al., (2011) and Rye 
et al., (2012) papers. It is important to note that this was standard practice at the time  
and publications for medical journals were written primarily by medical doctors not 
nurses. 
In the original submission of my thesis in chapter two, it was noted that in several 
places for the Li et al., 2006a and  2006b; White et al., 2011; and Rye et al., 2012 
articles I had used the term “my” publications. This was not to deceive the reader but 
instead to highlight that my name was very much part of that “et al.” collective. This 
has since been corrected. 
When discussing the importance of audit and research with medical colleagues, audit 
appears to take second place to research, and as such, is deemed of less value. In 





importance was evidenced by my own audit in paracentesis, where I was able to 
demonstrate the value of a nurse-led service to improve patient care and save 
thousands of pounds for the Trust (chapter 2).  Moreover, the Li et al., (2006a; 2006b) 
changed medical practice within the NHS Trust and the White et al., (2011), 
retrospective audit revealed that in contrast to European haemochromatosis 
guidelines (EASL, 2010), where they do not test for H63D homozygotes, 38% of H63D 
homozygotes developed iron over load and therefore, should be offered long term 
follow up. 
In 2016, I became a lecturer within an HEI, teaching advanced practice skills to post 
graduate professionals allied to medicine. Working within an HEI, the research ethos 
perceptively changed, and I was actively encouraged to write articles for publication, 
giving the opportunity from a pedagogical viewpoint, to raise awareness and 
understanding regarding liver disease and awarded funding to undertake research 
studies. Because of my research reputation, as evidenced by my involvement with 
NICE and published papers, I was requested to write an article for hepatology section 
of Gastrointestinal Nursing Journal (Mortimore, 2016a). This is the only UK journal 
exclusively dedicated to gastrointestinal, stoma care and hepatology nurses and is 
endorsed by the British Society of Gastroenterology (BSG). Therefore, I felt that this 
was the most pertinent journal to disseminate information regarding liver disease, 
diagnosis, treatment, and management. 
After searching the literature, I commented that despite the increasing prevalence of 
liver disease affecting all aspects of medicine and nursing (Williams et al., 2018; 
Williams, 2015; RCN, 2013) there was dearth of taught liver courses for health 





professionals’ awareness of liver disease and in so doing, established the topic of this 
critical appraisal.  
Because of my research reputation, I was approached by several journal editors to 
author articles namely the Nursing Times, the British Journal of Nursing, Journal of 
Prescribing Practice and Practice Nursing. 
Since 2016, I authored over forty articles (appendix 9, 10). Although not all the articles 
are related to liver disease, they do showcase my considerable experience as an ACP 
and evidence that if provided with vested time, I can deliver. My multiple publications 
have led to invitations to be a peer reviewer for nursing and prescribing journals, and 
I currently peer review articles for the British Journal of Nursing (BJN), Nursing Times, 
and the Gastrointestinal Nursing Journal (GIN).  
Journal editors, in recognition of the requirement to improve HCPs’ knowledge 
regarding liver disease, treatment, and management, sought my approval to reprint 
several of my previously published articles. In 2017, I authored an article titled, Primary 
Biliary Cholangitis: symptoms, diagnosis, and treatment (Mortimore, 2017d) and this 
was reprinted in June 2019 in GIN, Journal of Prescribing Practice (JPP) and Practice 
Nursing Journal (PNJ), (Mortimore, 2019a, b, c). Later in 2019, I included a small 
addition titled, Primary Biliary Cholangitis an update on treatment (Mortimore, 2019d), 
published in GIN. In 2020, this article was republished as a supplement in three 
journals: GIN, JPP and PNJ (Mortimore, 2020a, b, c). A further article, examining 
nutrition and malnutrition in liver disease was published (Mortimore, 2019e) and then 
republished for the same three journals listed above (Mortimore, 2020a, b, c). All of 





important enough to disseminate to a wider audience and my publications were used 
as a platform to advance health professionals knowledge of liver disease. 
4.2 Continuing impact of my research 
The impact of my research has led to a number of invitations for radio interviews, 
charity appeals, increased frequency of venesection by the Blood Transfusion Service 
for haemochromatosis patients and approaches by pharmaceutical companies 
(appendix 11). The interest generated by my publications from international 
pharmaceutical companies reflects favourably on the University of Derby and 
highlights my impact as an internationally recognised researcher and policy influencer. 
In addition, I have successfully been awarded research grants which reflects 
favourably on the strength of my research (appendix 12). 
4.3 Widening Research Influence 
Since writing the introduction to this critical appraisal, my research reputation, as 
indicated by the ResearchGate score; a metric that measures scientific reputation 
based on how your research is received by your peers was 24.59. This increased to 
25.92 in March 2021 (appendix 2) and in June 2021, it further increased to 26.11 
(appendix 8). This increase in metric evidences my scientific reputation as it is within 
the top 17.5% of all researchers listed on ResearchGate. Being in the top 17.5%, 
validates my unique contribution to knowledge in the national and international arena 
and highlights my research affiliation with the University of Derby.  
4.4 Charity Education Manager 
In August 2020, I gained employment as HUK charity’s education manager for the UK. 
This position enables me to continue to disseminate my research and continue with 





management. Part of my remit is to author patient information sheets offering advice 
on how to deal with issues that can affect patients with haemochromatosis. 
4.5 Lecturer in Advanced Practice 
Within my role as an ACP and an educator of trainee ACP’s, I have published several 
informative articles not related to liver disease (appendix 9, 10). These publications 
and associated citations, as well as citations from publications relating to liver disease 
highlight my contribution at an international level.  
4.6 Acknowledged limitations and strengths of my research journey 
Undertaking my own research was underpinned by my knowledge and experience 
honed over many years, where I could see gaps in knowledge and care but most 
importantly, gained the acumen to make change happen. Making change happen, took 
time. My nursing and research career is reflected in Benner’s (1984) five stages of 
novice to expert, but I now feel I have reached beyond this level of expert (figure 2) as 
indicated in the article by Mortimore et al., (2021). 
Commencing my nursing student hospital training in the early 1980s was a world away 
from the university degree student nurses today. Bullying was rife in the 1980’s, and 
accepted behaviour. If you were different, which is now known as the Tall Poppy 
Syndrome, where people who stand out from the ‘norm’ because of their abilities, 
qualities, intellect, or because they have achieved great success can be subject to 
bullying (Gillespie et al., 2017; Dediu, 2015; Meissner, 1986).  
I recognise I was a product of the age of “handmaiden to the doctors” but this was an 
expected role of being a nurse at the time. My early research experience reflects this 
attitude; my name was not placed on research papers despite being key in producing 
the scientific work. Even more interesting was that at the time, it did not concern me, 





have made me stronger, persistent and has taught me to treat people with kindness 
and respect because I appreciate what it is like to be ignored and circumvented. 
However, my bright-eyed perspective does still irritate people and on a personal note 
it can be difficult even now to be noticed or taken seriously. Attaining Ph.D. status will 
help me to feel more confident in my own abilities. However, I will always encourage 
and support my students and peers to ensure that they are treated with respect and 
rightfully acknowledged.  
4.7 Full circle 
In 2006, in recognition of my extensive input into anaesthetic research I was placed 
as first author on published research findings (Casey et al., 2006). I was grateful of 
this acknowledgement from previous experience where my input was ignored. This 
publication heralded a paradigm shift in my thinking and gave me the encouragement, 
confidence and drive to be involved in research and to write informative articles to 
increase health professionals’ knowledge of liver disease.  
My ambition, as a lecturer in a HEI, is to instil this confidence and drive in my students, 
and since 2019, I have co-authored and published eleven student articles (appendix 
9,10). Moreover, I have actively encouraged my colleagues to publish (Reynolds and 
Mortimore, 2021a, 2021b and 2018; Mortimore and Mayes, 2019; Watson and 
Mortimore, 2018/2019; Lewis and Mortimore 2018 (appendix 10). 
4.8 Professional Impact  
I am recognised as one of the few academics within the university who endeavours 
and succeeds in publishing students work. In 2020 alone, I co-authored seven 
published articles with students from the University of Derby, with two further articles 
submitted, awaiting double-blind peer review. Furthermore, I have two further articles 





In an article titled, ‘How many articles should a postdoc publish?’ it suggests that many 
postdoctoral academics do not publish (Tetzner, 2020). In contrast to this observation 
and in consideration that I have not yet attained postdoctoral status, I have a proven 
track record of publishing which is considered a reliable indicator of future productivity 
and impact in scientific and academic careers. Moreover, by actively encouraging my 
students and colleagues to write and submit for publication I hope to inspire them to 
be the writers, educators, and researchers of tomorrow.  
4.9 Aims of the thesis 
The aim of this thesis was to demonstrate, through my research and published 
literature that the impact of my research, nursing practice and published papers is: 
• advancing health professionals’ knowledge of liver disease within national and 
international arenas and 
• that my research has improved standards of medical and nursing care for 
patients receiving treatment for liver disease 
Both aims have been evidenced by my involvement in writing national NICE guidelines 
and Quality Standards on liver disease as discussed in chapter three. In addition, my 
research highlighted the disparity in care for patients undergoing venesection across 
the British Isles which led to me co-authoring venesection guidance (Francis, 
Mortimore and HUK, 2020). This is available from all British libraries and is freely 
available as an e-book for international audiences and worldwide dissemination. 
• that by listening and responding to patient experiences guides research and 
assists in the development of educational resources 
As well as publishing guidance and writing informative articles for health professionals 





booklets for people diagnosed with haemochromatosis such as cardiomyopathy and 
skin conditions (figure 7).  
 
Figure 5:  common skin conditions and cardiomyopathy booklets authored by Gerri Mortimore 





In 2021, I developed an educational module on haemochromatosis, freely available to 
any health care professionals, endorsed by the RCN and worth four continuing 
professional development (CPD) points (figure 6). Moreover, listening to the patient 
voice led me to devise my own research titled “Living with genetic haemochromatosis” 
in which posters were presented to the RCGP three day conference in October 2019 
and another poster presented at the International Liver Conference (ILC) hosted by 
EASL in June 2021.  
 
Figure 6:  RCN accredited haemochromatosis module authored by Gerri Mortimore. Available 
at: www.huk.org.uk (accessed 28th June 2021). 
My expertise regarding Haemochromatosis led to an invitation from HUK, to deliver 
live webinars to GPs within CCG’s on the diagnosis, treatment, and management of 
haemochromatosis, as well as informing GPs of patient experiences from the 





Liverpool CCG and I have presented monthly webinars since. The GPs who attend 
are awarded CPD points, which are essential for their General Medical Council 
revalidation.  
The final aim was to demonstrate  
• the impact of my research contribution and how this has influenced my 
professional standing 
Due to my expertise in liver disease I was awarded the title of NICE Nurse Expert 
Advisor in 2015, and in May 2021 was invited to be part of the Specialist Interest Group 
(SIG) in haemochromatosis as part of the BASL in June 2021, in which I  presented to 
the group the disparity in care for people with haemochromatosis and to highlight the 
Venesection Best Practice Guidelines (Francis, Mortimore and HUK).  I was the only 
nurse in attendance, the rest were medics. In May 2021, I was requested and delivered 
a podcast for the Gastrointestinal Nursing journal on haemochromatosis. Being a 
member of the APPG (chapter 3) additionally endorses my expertise.  
Due to my  publications (appendix 10) I was  contacted by a large pharmaceutical 
company to assist in the authoring of educational modules for HCPs. This again 
validates my expert status and professional influence and demonstrates how I assisted 
in developing further educational courses. 
This appraisal has evidenced that listening and responding to patient experiences 
guided my research, which was fundamental in the development of clinical guidelines 
and educational resources all of which have advanced health professional knowledge. 







This thesis provides a coherent collection of research that evidences how my 
knowledge, experience has influenced practice standards and processes, which 
impact on current and future healthcare delivery. This is clearly evidenced by direct 
dialogue with government and my contributions to national guidance which have 
reached international audiences. 
The evidence presented within this appraisal supports that I have reached expert 
status (Benner, 1984) but arguably may have surpassed this level to become an 
advanced expert and an internationally recognised researcher and policy influencer 
(Mortimore et al., 2021), (figure 2). All my published research and informative articles 
have been used as a platform to advance health professionals’ knowledge of liver 
disease and influence policy.  I consider that this body of research has helped shape 
the care that will be provided today and, in the future, to improve or transform patient 
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University of Derby 2020 press release regarding venesection guideline. 
 
Press release 
22 June 2020 
 er   lecturer’s or  helps to create nursing guide to treat common genetic condition  
The work of a University of Derby academic has helped a UK health charity to launch a guide which 
                                            UK’                      y conditions. 
Gerri Mortimore, Lecturer in Post-Registration Health Care at the University, has worked with 
Haemochromatosis UK to help nursing staff treat people with haemochromatosis, which affects an 
estimated 400,000 people across the UK. 
The condition is caused by the storing of too much iron in the body, which can result in liver, heart 
and pancreatic problems. Its most common symptoms though are chronic fatigue and a 
discoloration of the skin. 
Treating the condition involves taking blood from a patient at regular intervals to bring iron levels 
down. However, differing guidance for nurses and healthcare professionals to follow has raised 
concerns about consistency of care for patients. 
          Y      F              ’         T     ’     F          T ust in London, worked with 
Haemochromatosis UK and obtained the endorsement of the Royal College of Nursing to produce a 
single set of nurse-led guidelines for venesection best practice. 
Gerri, who addressed fellow academics about her work at the Universit          ’  R            
K                                T        (18 J   )        “T                                    
set of guidelines, written by nursing professionals and based on the best practice available, was clear 
if the condition was to be treated effectively. There is no known cure for the condition, so regular 
treatment to lower iron levels in the bloodstream is required. 
“T                                                                                                   
and healthcare professionals are clear about the most effective way of caring for patients. That can 
then help manage the condition and reduce the prospect of it causing more serious complications 
with their health in future. It also provides patients with the assurance that wherever they live in the 





The project has earned awards from two major organisations working for the wellbeing of hospital 
                         L            T           ’            . T              also have the support 
of a group of MPs who sit on the All Party Parliamentary Haemochromatosis Group. 
     M                                               UK        “T         -winning initiative is 
the culmination of over three years’ work with more than 200 nurses and other healthcare 
professionals to identify, document and coalesce best practice for venesection nursing procedures. 
  ’                                                                                                 
by the Royal College of Nursing as national best practice guidance. Our charity is delighted to have 
                                                                                   .” 
To find out more about the condition, visit www.haemochromatosis.org.uk 




















BJN nurse of the year award winners 
 







Gerri Mortimore wins Nurse of the Year Award 
  
Gerri Mortimore, Lecturer in Advanced Practice, won the 
prestigious Nurse of the Year Award at the British 
Journal of Nursing Awards 2021. Sponsored by The 
Nursing and Midwifery Council, this award recognises an 
individual who has made an outstanding achievement in 
nursing this year. 
  
The awards were announced at a virtual ceremony hosted by NHS Doctor and TV Presenter 
Dr Ranj Singh on Monday 8 March. 
  
                                            Y      F               ’         T     ’     
Foundation Trust. In the award entry, Gerri and Yvonne highlighted their work with 
Haemochromatosis UK and their research into venesection, a common clinical procedure 







patients across the country with genetic haemochromatosis, polycythaemia vera, idiopathic 
and secondary erythrocytosis.  
  
The project, which involved input from over 200 nurses across the UK and Ireland, culminated 
in the Venesection Best Practice Guidelines, the only resource specific to this subject. 
  
                                         “                                          Y    
     .                                  ’                                           
undergoing therapeutic venesection. 
  
“                                      UK                                      
developing this valuable resource, which has been recognised for its significance by the Royal 
College of Nursing who have endorsed the guidance.” 
  
Commenting on the award, Dr Paula Holt MBE, Pro Vice-Chancellor Dean of the College of 
                                           “T                         Year is an outstanding 
achievement and richly deserved. 
  
“T                       B       J                                               ’           
and research has had on improving patient safety, through the development of best practice 
                        .” 
  
For more information on the British Journal of Nursing Awards, please visit the website. 
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In October 2019, I presented preliminary findings gathered from the “Living with 
genetic haemochromatosis” study (Mortimore and Woodward, 2019), at the Royal 
College of General Practitioners (RCGP), 3-day conference.  
In January 2020, I delivered a 30-minute presentation at the 7th National Nursing 
Gastrointestinal Conference, regarding haemochromatosis, its diagnosis, treatment, 
and long-term management, disseminated the primary findings from my qualitative 
study (Mortimore and Woodward, 2019) and announced the publication of the 
Venesection Best Practice Guidelines (Francis, Mortimore and HUK, 2020). 
The research findings from Mortimore and Woodward (2019) Living with genetic 
haemochromatosis study and the publication of the venesection Best Practice 
Guidelines (Francis, Mortimore and HUK, 2020) were presented at the 7th National 
Nursing Gastrointestinal Conference in January 2020. In June 2020, I presented at the 
University of Derby’s University Research and Knowledge Exchange Conference 
regarding my ongoing research into genetic haemochromatosis (Mortimore and 
Woodward, 2019) including the findings from the draft Freedom of Information report 
(Mortimore and McClements, 2020a) presented to Parliament in February 2020.  
In November 2020, I presented at a celebration event to showcase the advantages of 
pharmacists working in Integrated Urgent Care, hosted by the University of Derby in 
partnership with Health Education England (HEE) and NHS England, Scotland, Wales, 
and Northern Ireland. This gave me the opportunity to discuss with the delegates that 
the opportunities of advanced practice roles could allow them to achieve expert status 
(Benner, 1984) and the possibility of exceeding this level attainment. 
Appendix 7 
Letter to  ecretary of  tate for  ealth and  ocial care after reading ‘State of 









































Co-authored publications since 2016 
 
Since 2016, I authored the following: Reynolds and Mortimore (2021a, b); Mortimore 
(2020a, b, c, d, e, f,); Francis,  Mortimore, HUK (2020);  Boyer and Mortimore (2020); 
Dexter and Mortimore (2020); Toplis and Mortimore (2020 a, b); Bailey and 
Mortimore (2020); Johnson, Francis and Mortimore (2020); Toplis and Mortimore 
(2019);  Hudson and Mortimore (2019); Mortimore (2019a, b, c); Mortimore and 
Mayes (2019); Redfern and Mortimore (2019); Mortimore (2019d, e); Parker and 
Mortimore (2019); Watson and Mortimore (2018/2019); Mortimore (2018a, b, c, d, 
e); Lewis and Mortimore (2018); Reynolds and Mortimore (2018); Mortimore 


















































































Continuing impact of my research 
BBC radio news interview. 
My expertise in liver disease led to three interviews by BBC Radio Derby regarding 
the topic of alcohol and the liver. One invitation followed on from an evening sessional 
talk held at the University of Derby in which I discussed alcohol, its effects and 
demonstrated how we all drink too much. BBC Derby were in attendance and 
requested an interview to discuss the topic of “Dry January” shortly after.   
Blood Transfusion Service 
The evidence within the FOI reports (Mortimore and McClements 2020; 2020a) was 
presented to the English and Scottish Blood Transfusion Service (BTS) who have 
since agreed to allow people diagnosed with GH, once in the maintenance stage of 
treatment, to donate their blood at their centres, on a more frequent basis than is 
currently permissible. The blood donated to BTS will be used for blood products, unlike 
the venesected blood in hospitals which is discarded due to lack of facilities and staff 
to centrifuge the blood into blood products. With regards to blood shortages, this 
exceptional outcome is an astonishing fact, and the evidence within this report has 
contributed to improving patient care. 
BBC Radio 4 Charity appeal 
The data within the FOI reports (Mortimore and McClements 2020, 2020a) and the 
Venesection Best Practice Guidance (Francis, Mortimore and HUK, 2020) was used 
as evidence for HUK’s charity appeal, launched in February 2021, on BBC Radio 4 by 
actor Stephen McGann. Radio 4 has far reaching influence and we are hoping that 







It was because of my published literature on liver disease that Eisai, a Japanese 
pharmaceutical company with worldwide subsidiaries, became aware of my expertise. 
These publications were: Nutrition and Malnutrition in Liver Disease: an overview 
(Mortimore, 2020d; 2020e; 2020f; 2019e); Gallbladder Cancer: nursing role in end-
of-life care (Mortimore, 2018); Dying from Liver Disease: the importance of end of life 
discussions (Watson and Mortimore, 2018); Primary Sclerosing Cholangitis: a 
premalignant condition (Mortimore, 2017) and my contribution to the Cirrhosis 
Guideline (NICE [CG50] 2016). 
Eisai requested my assistance in developing a UK patient survey on hepatocellular 
cancer. Although this will be several years in development, it is planned to be 
published with me as a co-author alongside oncologists, oncology nurses and 
hepatologists. Eisai additionally requested my expertise to consult on the hepatology 
aspects of e-learning modules for nurses, regarding hepatocellular cancer aetiology, 
treatment, and management. These modules will be employed for continuing 
professional development (CPD) for nurses, across the UK and possibly Europe. Once 
the modules are authored, Eisai plan to apply to the RCN for e-module CPD 
endorsement. This necessitated filming of dialogue between myself and an oncologist. 
It was because of my delivery and knowledge base I was again approached by Eisai 
to request whether I would be willing to address their UK and Republic of Ireland 
medical team to discuss issues facing the NHS and patients regarding the Covid-19 
pandemic. This was aired as a live meeting in December 2020. Being contacted and 
requested to assist in projects by an international pharmaceutical company not only 






In April 2020, I was contacted by Intercept Pharmaceuticals, an American 
biopharmaceutical company focusing on the development of novel synthetic bile acid 
analogues to treat chronic liver diseases. They contacted me as a direct result my 
published articles on Primary Sclerosing Cholangitis (PSC) (Mortimore, 2017c) and 
Primary Biliary Cholangitis (PBC) (Mortimore, 2019a, b, c; 2018e; 2017d). Due to the 
Covid-19 lockdown, a phone meeting was arranged to discuss potential ideas for non-
alcoholic fatty liver disease (NAFLD) publications and projects specifically for nurse 



















My research experience as an academic researcher within an HEI was in sharp 





NHS it was acknowledged by RCP (2016) and Brown, Hewison, Gale, Snelling and 
Shneerson, (2015) that the biggest barrier to research was lack of protected time and 
funding. Working within the HEI I was granted allotted scholarly hours to contribute 
articles as part of Research Excellence Framework (REF) and actively encouraged to 
apply for funding to undertake my own research studies. Being awarded REF hours 
again highlights acknowledgement from the university that I am contributing to the 
university’s research framework. 
Successful funding awarded was from: 
• University Research and Knowledge Exchange Office (URKEO) awarded 
£3570 in January 2020 from after successful application from the QR Strategic 
Priorities Fund, to disseminate impact of research at a policy level. This was in relation 
to freedom of information received from NHS Trusts re the treatment, management of 
GH and guidelines used, or not. A report was written to be presented to the Houses of 
Parliament, All Party Parliamentary Group, in February 2020. A final report was 
authored in September 2020. This has been sent to all UK Parliamentarians and to 
the BTS. 
• College REF Investment Fund awarded £12,500 on 02/02/18 This 
represented £5,000 – maximum award for seed funding and £7,500.00 – maximum 
award for the mini-sabbatical. To commence my qualitative study “Living with Genetic 
Haemochromatosis”. 
• College Scholarship and Research Strategy awarded £5000 on 11/06/18, to 
continue with my research into “Living with Genetic Haemochromatosis”. 
Being successful in these funding awards can be, in part, attributed to my consistent 





informative articles on liver disease, both of which have advanced healthcare 
professionals’ knowledge of liver disease within a national and international arena.  
Furthermore, in recognition of my research and publication outputs I have been 
identified by the University, as a staff member with a Significant Responsibility for 




















An article, published in the British Journal of Nursing on pulmonary emboli (Toplis and 
Mortimore 2020), was cited by a Chinese paper published in the Lancet preprints in 
March 2020. The authors released findings from their experiences with patients 
diagnosed with the COVID-19 virus who, in 10%, will develop an acute pulmonary 
embolus secondary to an inflammatory response. In addition to this, an article titled, 
Ludwig’s angina (Parker and Mortimore, 2019) has been cited in several international 
journals, with a further article titled, Advanced Nurse Practitioners: the NHS England 
framework (Reynolds and Mortimore, 2018) has been cited five times (appendix 10), 
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